http://debianws.lexgopc.com/wiki143/index.php?action=history&feed=atom&title=Expert_Opinion_on_Investigational_Drugs 2026-06-02T07:31:18Z Revision history for this page on the wiki MediaWiki 1.43.1 http://debianws.lexgopc.com/wiki143/index.php?title=Expert_Opinion_on_Investigational_Drugs&diff=7992048&oldid=prev 2023-08-11T03:34:12Z

<p><span class="autocomment">top: </span>Add italic formatting to normally-italicized text in hatnote to effectively de-italicize it (per <a href="/wiki143/index.php?title=WP:ITHAT&amp;action=edit&amp;redlink=1" class="new" title="WP:ITHAT (page does not exist)">WP:ITHAT</a>)</p> <p><b>New page</b></p><div>{{hatnote|Not to be confused with &#039;&#039;[[Current Opinion in Investigational Drugs]]&#039;&#039;, a different publication which shares the former name of this journal.}}<br /> {{Infobox Journal<br /> | title = Expert Opinion on Investigational Drugs<br /> | formername=Current Opinion in Investigational Drugs<br /> | cover =<br /> | discipline = [[Pharmacology]]<br /> | abbreviation = Expert Opin. Investig. Drugs<br /> | publisher = [[Taylor &amp; Francis]]<br /> | country = [[United Kingdom]]<br /> | history = 1992-present<br /> | frequency = Monthly<br /> | impact = 6.498<br /> | impact-year = 2021<br /> | website = http://informahealthcare.com/loi/eid<br /> | ISSN = 1354-3784<br /> | eISSN = 1744-7658<br /> | CODEN = EOIDER<br /> | OCLC = 30379431<br /> }}<br /> &#039;&#039;&#039;&#039;&#039;Expert Opinion on Investigational Drugs&#039;&#039;&#039;&#039;&#039; is a monthly [[Peer review|peer-reviewed]] [[medical journal]] covering developments in [[pharmaceutical sciences|pharmaceutical research]], from animal studies through to early clinical investigation. The journal&#039;s scope includes [[therapy|therapeutics]] in many areas: [[Lung|pulmonary]]-[[allergy]], [[dermatology]], [[Human gastrointestinal tract|gastrointestinal]], [[arthritis]], [[Infection|infectious disorders]], [[Endocrine system|endocrine]] and [[Metabolism|metabolic]], [[Central nervous system|central]] and [[peripheral]] [[nervous system]], [[Circulatory system|cardiovascular]] and [[Kidney|renal]], and [[oncology]].<br /> <br /> The journal was established by [[Current Drugs]] in 1992, under the title &#039;&#039;Current Opinion in Investigational Drugs&#039;&#039;. In 1994, the journal was acquired by [[Ashley Publications]], who published it until 2015, when it was acquired by [[Taylor &amp; Francis]]. The current Editor-in-Chief is Dr. Naim Alkhouri (Texas Liver Institute, San Antonio, Texas, USA). According to the [[Journal Citation Reports]], the Journal has a 2021 [[impact factor]] of 6.498. It is also indexed in [[MEDLINE]]. The journal is available online and in paper format.<br /> <br /> [[Category:Pharmacology journals]]<br /> [[Category:Monthly journals]]<br /> [[Category:Academic journals established in 1992]]<br /> [[Category:English-language journals]]<br /> [[Category:Expert Opinion journals]]<br /> <br /> <br /> {{pharma-journal-stub}}</div>

imported>LightNightLights